ChemoCentryx (CCXI) News Today → Urgent Nvidia Warning (From Altimetry) (Ad) Free CCXI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRishi Gupta's Net Worthbenzinga.com - February 22 at 7:19 AMChemoCentryx (NASDAQ:CCXI) Now Covered by Analysts at StockNews.commarketbeat.com - December 4 at 5:34 AMChemoCentryx, Inc. (NASDAQ:CCXI) Receives Consensus Rating of "Hold" from Analystsmarketbeat.com - November 28 at 1:49 AMAMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX - PR Newswireprnewswire.com - October 20 at 9:26 AMAMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYXfinance.yahoo.com - October 20 at 9:26 AMmarketbeat.com - October 20 at 6:04 AMChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings - Yahoo Financefinance.yahoo.com - October 17 at 10:19 AMChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetingsfinance.yahoo.com - October 17 at 10:19 AMChemoCentryx Inc Shares Close in on 52-Week High - Market Mover - Nasdaqnasdaq.com - October 15 at 9:39 AMChemoCentryx, Inc. (NASDAQ:CCXI) Given Consensus Rating of "Hold" by Brokeragesmarketbeat.com - October 9 at 2:36 AMChemoCentryx Inc Shares Approach 52-Week High - Market Mover - Nasdaqnasdaq.com - October 7 at 8:50 AMIs ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year? - Nasdaqnasdaq.com - October 6 at 12:49 PMIs ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - October 6 at 12:49 PMChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewswireglobenewswire.com - October 5 at 11:12 AMChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meetingfinance.yahoo.com - October 5 at 11:12 AMChemoCentryx (NASDAQ: CCXI)fool.com - September 30 at 7:22 PMBiotech Valuations Remain In a Slump - TheStreetthestreet.com - September 24 at 1:09 PMAmgen CEO Sees Tougher Sleddin - GuruFocus.comgurufocus.com - September 19 at 4:06 PMThese 10 Biotech Stocks Would Have Netted You $10000 More This Year - Investor's Business Dailyinvestors.com - September 19 at 4:06 PMSPDR S&P Biotech ETF Experiences Big Inflow - Nasdaqnasdaq.com - September 15 at 6:14 PMAmgen (AMGN): Growing Doubts About The Future - Seeking Alphaseekingalpha.com - September 14 at 5:12 PMChemoCentryx, Inc. (NASDAQ:CCXI) Receives Consensus Rating of "Hold" from Brokeragesmarketbeat.com - September 14 at 2:37 AM2022-09-13 | NDAQ:CCXI | Press Release | ChemoCentryx Inc. - Stockhousestockhouse.com - September 13 at 3:48 PMINVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.'s Directors and Officers for Breach of Fiduciary Duties – CCXI - Business Wirebusinesswire.com - September 13 at 3:48 PMChemoCentryx (NASDAQ:CCXI) – INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCent - Benzingabenzinga.com - September 13 at 3:48 PMAmgen Stock Is Looking Interesting On The Dip (NASDAQ:AMGN) - Seeking Alphaseekingalpha.com - September 13 at 10:48 AMWhy Is ChemoCentryx (CCXI) Up 1.4% Since Last Earnings Report? - Nasdaqnasdaq.com - September 7 at 8:37 PMWhy Is ChemoCentryx (CCXI) Up 1.4% Since Last Earnings Report?finance.yahoo.com - September 7 at 3:37 PMCCXI.N - ChemoCentryx Inc | Stock Price & Latest News | Reutersreuters.com - September 5 at 9:06 PMCCXI.O - ChemoCentryx Inc | Stock Price & Latest News | Reutersreuters.com - September 4 at 7:07 PMChemocentryx (CCXI) – ChemoCentryx's Return On Capital Employed Insights - Benzingabenzinga.com - September 1 at 6:16 PMAerie Pharmaceuticals (AERI), Chemocentryx (CCXI) – SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates CCX - Benzingabenzinga.com - August 31 at 11:36 PMChemoCentryx, Inc. (NASDAQ:CCXI) Sees Significant Increase in Short Interestmarketbeat.com - August 31 at 8:22 AMChemocentryx (CCXI) – INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, In - Benzingabenzinga.com - August 31 at 3:19 AMAmgen (AMGN) Outperforms Industry Year to Date: What's Next? - Nasdaqnasdaq.com - August 30 at 10:19 PM2022-08-30 | NDAQ:CCXI | Press Release | ChemoCentryx Inc. - Stockhousestockhouse.com - August 30 at 10:19 PMBiotech Stocks: These 10 Have A 40% Gain This Year (And Nothing To Do With Covid) - Investor's Business Dailyinvestors.com - August 29 at 11:11 AM2022-08-25 | NDAQ:CCXI | Press Release | ChemoCentryx Inc. - Stockhousestockhouse.com - August 25 at 1:51 PM2022-08-24 | NDAQ:CCXI | Press Release | ChemoCentryx Inc. - Stockhousestockhouse.com - August 24 at 10:48 PMChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferencesfinance.yahoo.com - August 24 at 8:59 AM3 Biopharmas on Buyout Watch - The Motley Foolfool.com - August 22 at 9:01 AMSHAREHOLDER ALERT: Weiss Law Reminds CCXI, HNGR, U, and IRBT Shareholders About Its Ongoing Investigations - PR Newswireprnewswire.com - August 18 at 6:11 PMMergers Rebound. Here's Who Will Benefit. - Barron'sbarrons.com - August 18 at 6:11 PMChemoCentryx (CCXI) Now Trades Above Golden Cross: Time to Buy? - Nasdaqnasdaq.com - August 18 at 6:11 PMHere's Why ChemoCentryx (CCXI) is a Great Momentum Stock to Buy - Yahoo Financefinance.yahoo.com - August 17 at 7:06 AMHere's Why ChemoCentryx (CCXI) is a Great Momentum Stock to Buy - Nasdaqnasdaq.com - August 16 at 8:42 PMChemoCentryx (CCXI) Now Trades Above Golden Cross: Time to Buy? - Yahoo Financefinance.yahoo.com - August 16 at 8:42 PMChemoCentryx (CCXI) Now Trades Above Golden Cross: Time to Buy?finance.yahoo.com - August 16 at 3:41 PMHere's Why ChemoCentryx (CCXI) is a Great Momentum Stock to Buyfinance.yahoo.com - August 16 at 3:41 PMBiotech Is Still in a Bull Market. But for How Long? - Barron'sbarrons.com - August 15 at 1:09 PM Get ChemoCentryx News Delivered to You Automatically Sign up to receive the latest news and ratings for CCXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Could Your Accounts Be Frozen? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit CCXI Media Mentions By Week CCXI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CCXI News Sentiment▼0.190.43▲Average Medical News Sentiment CCXI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CCXI Articles This Week▼00▲CCXI Articles Average Week Get ChemoCentryx News Delivered to You Automatically Sign up to receive the latest news and ratings for CCXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alkermes News Today Amicus Therapeutics News Today Madrigal Pharmaceuticals News Today Geron News Today Dynavax Technologies News Today Ionis Pharmaceuticals News Today Ironwood Pharmaceuticals News Today Ligand Pharmaceuticals News Today MannKind News Today Innoviva News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CCXI) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ChemoCentryx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
